Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 59

1.

Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.

Liu S, Goldstein RH, Scepansky EM, Rosenblatt M.

Cancer Res. 2009 Nov 15;69(22):8742-51. doi: 10.1158/0008-5472.CAN-09-1541. Epub 2009 Nov 3.

2.

MMP7 shedding of syndecan-1 facilitates re-epithelialization by affecting alpha(2)beta(1) integrin activation.

Chen P, Abacherli LE, Nadler ST, Wang Y, Li Q, Parks WC.

PLoS One. 2009 Aug 10;4(8):e6565. doi: 10.1371/journal.pone.0006565.

3.

Syndecans as receptors and organizers of the extracellular matrix.

Xian X, Gopal S, Couchman JR.

Cell Tissue Res. 2010 Jan;339(1):31-46. doi: 10.1007/s00441-009-0829-3. Epub 2009 Jul 14. Review.

PMID:
19597846
4.

Syndecan-1 enhances the endometrial cancer invasion by modulating matrix metalloproteinase-9 expression through nuclear factor kappaB.

Oh JH, Kim JH, Ahn HJ, Yoon JH, Yoo SC, Choi DS, Lee IS, Ryu HS, Min CK.

Gynecol Oncol. 2009 Sep;114(3):509-15. doi: 10.1016/j.ygyno.2009.05.027. Epub 2009 Jun 17.

PMID:
19539355
5.

Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility.

Tomar A, Schlaepfer DD.

Curr Opin Cell Biol. 2009 Oct;21(5):676-83. doi: 10.1016/j.ceb.2009.05.006. Epub 2009 Jun 12. Review.

6.

Proteoglycan signaling co-receptors: roles in cell adhesion, migration and invasion.

Mythreye K, Blobe GC.

Cell Signal. 2009 Nov;21(11):1548-58. doi: 10.1016/j.cellsig.2009.05.001. Epub 2009 May 8. Review.

7.

Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited.

Sabeh F, Shimizu-Hirota R, Weiss SJ.

J Cell Biol. 2009 Apr 6;185(1):11-9. doi: 10.1083/jcb.200807195. Epub 2009 Mar 30.

8.

Fascin overexpression correlates with positive thrombospondin-1 and syndecan-1 expressions and a more aggressive clinical course in patients with gallbladder cancer.

Roh YH, Kim YH, Choi HJ, Lee KE, Roh MS.

J Hepatobiliary Pancreat Surg. 2009;16(3):315-21. doi: 10.1007/s00534-009-0046-1. Epub 2009 Mar 4.

PMID:
19259612
9.

Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.

Beauvais DM, Ell BJ, McWhorter AR, Rapraeger AC.

J Exp Med. 2009 Mar 16;206(3):691-705. doi: 10.1084/jem.20081278. Epub 2009 Mar 2.

10.

Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.

Yamazaki D, Kurisu S, Takenawa T.

Oncogene. 2009 Apr 2;28(13):1570-83. doi: 10.1038/onc.2009.2. Epub 2009 Feb 23.

PMID:
19234490
11.

Tropomyosin and ADF/cofilin as collaborators and competitors.

Kuhn TB, Bamburg JR.

Adv Exp Med Biol. 2008;644:232-49. Review.

PMID:
19209826
12.

Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion.

Narumiya S, Tanji M, Ishizaki T.

Cancer Metastasis Rev. 2009 Jun;28(1-2):65-76. doi: 10.1007/s10555-008-9170-7. Review.

PMID:
19160018
13.

Rho-signaling pathways in chronic myelogenous leukemia.

Kuzelová K, Hrkal Z.

Cardiovasc Hematol Disord Drug Targets. 2008 Dec;8(4):261-7. Review.

PMID:
19075636
14.

Expression of E-cadherin and syndecan-1 in axillary lymph node metastases of breast cancer with and without extracapsular extension.

Thanakit V, Ruangvejvorachai P, Sampatanukul P.

J Med Assoc Thai. 2008 Jul;91(7):1087-92.

PMID:
18839850
15.

Up-regulation of Rho/ROCK signaling in sarcoma cells drives invasion and increased generation of protrusive forces.

Rösel D, Brábek J, Tolde O, Mierke CT, Zitterbart DP, Raupach C, Bicanová K, Kollmannsberger P, Panková D, Vesely P, Folk P, Fabry B.

Mol Cancer Res. 2008 Sep;6(9):1410-20. doi: 10.1158/1541-7786.MCR-07-2174.

16.
17.

Syndecan-1 supports integrin alpha2beta1-mediated adhesion to collagen.

Vuoriluoto K, Jokinen J, Kallio K, Salmivirta M, Heino J, Ivaska J.

Exp Cell Res. 2008 Nov 1;314(18):3369-81. doi: 10.1016/j.yexcr.2008.07.005. Epub 2008 Jul 15.

PMID:
18657535
18.

Heparanase-2, syndecan-1, and extracellular matrix remodeling in colorectal carcinoma.

Peretti T, Waisberg J, Mader AM, de Matos LL, da Costa RB, Conceição GM, Lopes AC, Nader HB, Pinhal MA.

Eur J Gastroenterol Hepatol. 2008 Aug;20(8):756-65. doi: 10.1097/MEG.0b013e3282fc2649.

PMID:
18617780
20.

Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas.

Loussouarn D, Campion L, Sagan C, Frenel JS, Dravet F, Classe JM, Pioud-Martigny R, Berton-Rigaud D, Bourbouloux E, Mosnier JF, Bataille FR, Campone M.

Br J Cancer. 2008 Jun 17;98(12):1993-8. doi: 10.1038/sj.bjc.6604400. Epub 2008 Jun 10.

Supplemental Content

Support Center